BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33604316)

  • 1. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
    Diesinger T; Lautwein A; Bergler S; Buckert D; Renz C; Dvorsky R; Buko V; Kirko S; Schneider E; Kuchenbauer F; Kumar M; Günes C; Genze F; Büchele B; Simmet T; Haslbeck M; Masur K; Barth T; Müller-Enoch D; Wirth T; Haehner T
    Can J Gastroenterol Hepatol; 2021; 2021():8854432. PubMed ID: 33604316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    Diesinger T; Buko V; Lautwein A; Dvorsky R; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Buckert D; Bergler S; Renz C; Schneider E; Kuchenbauer F; Kumar M; Günes C; Büchele B; Simmet T; Müller-Enoch D; Wirth T; Haehner T
    PLoS One; 2020; 15(7):e0235990. PubMed ID: 32701948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.
    Diesinger T; Lautwein A; Buko V; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Dvorsky R; Buckert D; Bergler S; Renz C; Müller-Enoch D; Wirth T; Haehner T
    Physiol Rep; 2021 Mar; 9(6):e14795. PubMed ID: 33769703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway.
    Gong P; Cederbaum AI; Nieto N
    J Biol Chem; 2003 Aug; 278(32):29693-700. PubMed ID: 12777398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CYP2E1 enhances sensitivity of hepG2 cells to fas-mediated cytotoxicity.
    Yan QG; Shi JG; Zhang F; Zhao QT; Pang XW; Chen R; Hu PZ; Li QL; Wang Z; Huang GS
    Cancer Biol Ther; 2008 Aug; 7(8):1280-7. PubMed ID: 18497573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2E1 increases the sensitivity of hepatoma cells to vitamin K2.
    Li L; Wang L; Song R; Chen G; Liu Y
    Int J Oncol; 2017 May; 50(5):1832-1838. PubMed ID: 28339022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
    Surapaneni KM; Priya VV; Mallika J
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2736-41. PubMed ID: 25317811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and properties of HepG2 cells that constitutively express CYP2E1.
    Wu D; Cederbaum AI
    Methods Mol Biol; 2008; 447():137-50. PubMed ID: 18369917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor.
    Gao J; Wang Z; Wang GJ; Gao N; Li J; Zhang YF; Zhou J; Zhang HX; Wen Q; Jin H; Qiao HL
    Mol Carcinog; 2018 Oct; 57(10):1371-1382. PubMed ID: 29917271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress.
    Marí M; Cederbaum AI
    Hepatology; 2001 Mar; 33(3):652-61. PubMed ID: 11230746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity.
    Pérez MJ; Cederbaum AI
    Free Radic Biol Med; 2002 Jul; 33(1):111-27. PubMed ID: 12086689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.
    Linhart K; Bartsch H; Seitz HK
    Redox Biol; 2014; 3():56-62. PubMed ID: 25462066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage.
    Lee M; Bae MA
    J Nutr Biochem; 2007 May; 18(5):348-54. PubMed ID: 16963249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma.
    Ho JC; Cheung ST; Leung KL; Ng IO; Fan ST
    Int J Cancer; 2004 Sep; 111(4):494-500. PubMed ID: 15239125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
    Pang YY; Li JD; Gao L; Yang X; Dang YW; Lai ZF; Liu LM; Yang J; Wu HY; He RQ; Huang ZG; Xiong DD; Yang LH; Shi L; Mo WJ; Tang D; Lu HP; Chen G
    Cancer Med; 2020 Nov; 9(21):8004-8019. PubMed ID: 32931665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity.
    Pérez MJ; Cederbaum AI
    Free Radic Biol Med; 2001 Apr; 30(7):734-46. PubMed ID: 11275473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.
    Lu Y; Zhuge J; Wang X; Bai J; Cederbaum AI
    Hepatology; 2008 May; 47(5):1483-94. PubMed ID: 18393316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.